[Edaily Starin KIM HYUNSIK Reporter] Girl group LE SSERAFIM (Kim Chae-won, Sakura, Heo Yoon-jin, Kazuha, Hong Eun-chae) returned to "The Jennifer Hudson Show." (Photo courtesy of Source Music, The Jennifer Hudson Show)(Photo courtesy of Source Music, The Jennifer Hudson Show)On the 15th (local time), LE SSERAFIM appeared on the popular U.S. talk show “The Jennifer Hudson Show” and performed their new song “Made My Night.” This marks LE SSERAFIM’s third appearance on “The Jennifer Hudson Show,” following their appearances in 2024 and last year. Host and singer Jennifer Hudson welcomed them back, introducing them as “K-pop superstars.” “Made My Night” is a pop-dance track that celebrates the joy of dancing all night with a special someone. It serves as the title track of their new single, released on the 11th. As LE SSERAFIM performed their new song, some audience members stood up, sang along, and enjoyed the performance. The camera also captured audience members wearing T-shirts featuring photos of LE SSERAFIM. Toward the end of the performance, Jennifer Hudson caught the audience’s attention by attempting the “ending pose” characteristic of K-pop music shows. After finishing their performance of the new song, LE SSERAFIM took time to answer questions from the audience and discuss the new song and their upcoming activities. Referring to their North American world tour, which kicks off on the 16th at Crypto.com Arena in Los Angeles, they said, “It’s a show everyone can enjoy, so please look forward to it.”
On the 13th, at the Samsung Medison Hongcheon Plant in Hongcheon County, Gangwon Province. Upon entering the newly constructed manufacturing building, a long line of automated production equipment was…
Pulmuone Corporate’s operating profit for the third quarter of this year fell to one-tenth of the level recorded in the same period last year. Although sales increased, profitability in its domestic b…
Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…